In this second extract, Cate Ambrose asked Mark to outline the challenges and specific considerations unique to valuing credit funds amid the pandemic.

Mark McMahon, Global Practice Leader and Head of Alternative Investment Services for Alvarez & Marsal Valuation Services spoke at a webinar hosted by EMPEA, the global industry association for private capital in emerging markets, on valuation issues during COVID-19. 

Valuation Tax expert Philip Antoon and Crown Jewel Insurance discuss why companies should parse out and valuate trade secrets in “The Value in Valuation” podcast

Embracing Technology to Meet the Changing Needs of the Private Equity Market

On this episode of A&M Conversation With, Senior Director Maria Nizza, from Alvarez & Marsal’s Valuation Services, discusses changes in the collateralized loan obligation market over the last 12 months, and what we should consider when valuing of CLOs.

On this episode of A&M Conversation With, Managing Directors David Riviere and Keith Browning, as well as Senior Directors Matt Stanfield and Art Hall sit down to discuss the growing digital presence within the supply chain.

On this episode of A&M Conversation With Managing Directors Richard Bibby and Mark McMahon converse with Ian Blance of Voltaire Advisors about factors PE fund managers take into consideration when thinking about outsourcing valuation.

On this episode of A&M Conversation With Managing Directors Richard Bibby and Mark McMahon converse with Ian Blance of Voltaire Advisors to identify some of the changes and issues that will affect valuation in PE Funds.

On this episode of A&M Conversation With, Managing Director Dr. David Gruber sits down with Managing Director Jay Burkett to discuss the essentials of risk management.

Patient engagement is critical, as behavioral (lifestyle) and social circumstances represent 40 percent and 15 percent, respectively, of the contributors to premature death. Patient engagement requires self-management and supportive provider and/or payer interventions.

On this episode of A&M Conversation With, Managing Director Dr. David Gruber sits down with Mark Finucane, Managing Director and Co-head of West Coast operations to discuss the need for risk stratification, and the impact of co-morbid depression, activity limitations and social determinants on the total cost of care.

On this episode of A&M Conversation With, Managing Director Dr. David Gruber sits down with Managing Director Stuart McLean to discuss the U.S. healthcare delivery system in terms cost, effectiveness and the barriers to the coordinated care delivery system.

Michael O’Dowd, a Managing Director with A&M’s Transaction Advisory Group, Managing Director Jeffrey Klein of the Private Equity Performance Improvement Group and Managing Director Art Ehuan of the Disputes and Investigations Group to discuss cybersecurity during the exit stage and the technical testing that is required to identify vulnerabilities.

Michael O’Dowd, a Managing Director with A&M’s Transaction Advisory Group sits down with Managing Directors Jeffrey Klein of the Private Equity Performance Improvement Group and Art Ehuan of the Disputes and Investigations Group to discuss the importance of assessing cyber during the post-acquisition stage.

Michael O’Dowd, a Managing Director with A&M’s Transaction Advisory Group sits down with Managing Directors Jeffrey Klein of the Private Equity Performance Improvement Group and Art Ehuan of the Disputes and Investigations Group to discuss the importance of assessing cyber during the pre-acquisition stage.